SPECTRAL DIAGNOSTICS WKN: A12HJ9 ISIN: CA8475771033 Kürzel: SD4 Forum: Aktien Thema: Hauptdiskussion
0,3875 USD
-5,49 %-0,0225
5. Dec, 02:10:00 Uhr,
Nasdaq OTC
Kommentare 18
Summer.76,
8. Nov 17:10 Uhr
0
https://spectraldx.com/spectral-third-quarter-corporate-update/
Summer.76,
01.08.2024 18:32 Uhr
0
https://financialpost.com/globe-newswire/spectral-medical-provides-july-tigris-trial-update
Summer.76,
22.02.2024 5:44 Uhr
0
https://finance.yahoo.com/news/spectral-medical-announces-amendment-extension-210000857.html
Spectral Medical Announces Amendment and Extension of Exclusive Supply and Distribution Agreement With Baxter Healthcare Corporation
Summer.76,
05.02.2024 18:50 Uhr
0
https://financialpost.com/globe-newswire/spectral-medical-provides-early-february-tigris-trial-update
Summer.76,
09.11.2023 19:58 Uhr
0
https://finance.yahoo.com/news/spectral-medical-announces-third-quarter-130000858.html
Summer.76,
30.05.2023 16:04 Uhr
0
https://finance.yahoo.com/news/spectral-medical-provides-favorable-tigris-120000727.html
Summer.76,
18.04.2023 16:35 Uhr
0
https://www.globenewswire.com/news-release/2023/04/18/2648924/0/en/Spectral-Medical-Announces-Positive-Results-of-EUPHAS-2-Clinical-Trial-Evaluating-PMX-in-Critically-Ill-Endotoxemic-Septic-Shock-Patients.html
Summer.76,
24.03.2023 15:20 Uhr
0
https://www.globenewswire.com/news-release/2023/03/24/2633936/0/en/Spectral-Medical-Announces-Fourth-Quarter-and-Fiscal-2022-Results-and-Provides-Corporate-Update.html
Summer.76,
10.03.2023 6:52 Uhr
0
https://www.globenewswire.com/news-release/2023/03/09/2624058/0/en/Spectral-Medical-Announces-the-Opening-of-Two-Additional-Tigris-Clinical-Trial-Sites.html
Summer.76,
10.11.2022 20:05 Uhr
0
https://www.globenewswire.com/news-release/2022/11/10/2553173/0/en/Spectral-Medical-Announces-Third-Quarter-Results-and-Provides-Corporate-Update.html
Summer.76,
02.11.2022 16:33 Uhr
0
https://www.globenewswire.com/news-release/2022/11/02/2546663/0/en/Spectral-Medical-Inc-Closes-10-8-Million-Public-Offering-and-Concurrent-Private-Placement.html
Summer.76,
06.10.2022 15:47 Uhr
0
https://www.globenewswire.com/news-release/2022/10/05/2529067/0/en/Spectral-Medical-Inc-Announces-Proposed-Public-Offering-of-Units-and-Private-Placement-of-Notes.html
Summer.76,
12.08.2022 17:15 Uhr
0
Spectral Announces Second Quarter Results and Provides Corporate Update
https://www.globenewswire.com/news-release/2022/08/12/2497562/0/en/Spectral-Announces-Second-Quarter-Results-and-Provides-Corporate-Update.html
Summer.76,
20.07.2022 18:20 Uhr
0
Spectral Medical Provides Update on Tigris Clinical Trial
https://www.globenewswire.com/news-release/2022/07/20/2482641/0/en/Spectral-Medical-Provides-Update-on-Tigris-Clinical-Trial.html
G
Gast-729245900,
11.07.2022 18:41 Uhr
0
🤔
Summer.76,
11.07.2022 15:58 Uhr
0
'US FDA Grants Spectral Medical Breakthrough Device"
.
https://www.globenewswire.com/news-release/2022/07/11/2477245/0/en/US-FDA-Grants-Spectral-Medical-Breakthrough-Device-Designation-for-Toraymyxin-PMX-for-the-Treatment-of-Endotoxemic-Septic-Shock.html
Meistdiskutiert
|
Thema | ||
---|---|---|---|
1 | DRONESHIELD LTD Hauptdiskussion | -8,16 % | |
2 | XRP zu USD Hauptdiskussion | -10,32 % | |
3 | Droneshield-Fakten und fundamentale Beiträge | -8,16 % | |
4 | BTC/USD Hauptdiskussion | +2,99 % | |
5 | PAG911 | -0,73 % | |
6 | NVIDIA Hauptdiskussion | +3,48 % | |
7 | EcoGraf Hauptdiskussion | +3,85 % | |
8 | Nikola Hauptforum | +5,39 % | |
9 | PAIN THERAPEUTICS Hauptdiskussion | -11,94 % | |
10 | Hyzon Motors Registered (A) Hauptdiskussion | -3,78 % | Alle Diskussionen |
Aktien
|
Thema | ||
---|---|---|---|
1 | DRONESHIELD LTD Hauptdiskussion | -8,16 % | |
2 | Droneshield-Fakten und fundamentale Beiträge | -8,16 % | |
3 | PAG911 | -0,73 % | |
4 | NVIDIA Hauptdiskussion | +3,49 % | |
5 | EcoGraf Hauptdiskussion | +3,85 % | |
6 | Nikola Hauptforum | +6,04 % | |
7 | PAIN THERAPEUTICS Hauptdiskussion | -12,48 % | |
8 | Hyzon Motors Registered (A) Hauptdiskussion | -3,79 % | |
9 | BAYER Hauptdiskussion | +0,96 % | |
10 | ALIBABA GROUP ADR Hauptdiskussion | -0,90 % | Alle Diskussionen |